Identification of estrogen-responsive genes involved in breast cancer metastases to the bone (original) (raw)

• Campbell FC, Blamey RW, Elston CW et al (1981) Oestrogen-receptor status and sites of metastasis in breast cancer. Br J Cancer 44:456–459
  PubMed CAS Google Scholar
• Kamby C, Rasmussen BB, Kristensen B (1989) Oestrogen receptor status of primary breast carcinomas and their metastases. Relation to pattern of spread and survival after recurrence. Br J Cancer 60:252–257
  PubMed CAS Google Scholar
• Koenders PG, Beex LVAM, Langens R et al (1991) Steroid hormone receptor activity of primary human breast cancer and patterns of first metastasis. Breast Cancer Res Treat 18:27–32
  Article PubMed CAS Google Scholar
• Fuqua SAW (2002) The role of estrogen receptors in breast cancer metastasis. J Mammary Gland Biol Neopl 6:407–417
  Article Google Scholar
• Mundy GR (2002) Metastasis to bone: causes, consequences and therapeutic opportunities. Nature Rev 2:584–593
  Article CAS Google Scholar
• Rosol TJ, Tannehill-Gregg SH, LeRoy BE et al (2003) Animal models of bone metastasis. Cancer 97(3 Suppl):748–757
  Article PubMed Google Scholar
• Jiang SY, Jordan VC (1992) Growth regulation of estrogen receptor-negative breast cancer cells transfected with complementary DNAs for estrogen receptor. J Natl Cancer Inst 84:580–591
  Article PubMed CAS Google Scholar
• Tonetti DA, Rubenstein R, DeLeon M et al (2003) Stable transfection of an estrogen receptor beta cDNA isoform into MDA-MB-231 breast cancer cells. J Steroid Biochem Mol Biol 87:47–55
  Article PubMed CAS Google Scholar
• Monroe DG, Getz BJ, Johnsen SA et al (2003) Estrogen receptor isoform-specific regulation of endogenous gene expression in human osteoblastic cell lines expressing either ERα or ERβ. J Cell Biochem 90:315–326
  Article PubMed CAS Google Scholar
• Levenson AS, Kwaan HC, Svoboda KM et al (1998) Weiss IM, Sakurai S, Jordan VC. Oestradiol regulation of components of the plasminogen-plasmin system in MDA-MB-231 human breast cancer cell stably expressing the oestrogen receptor. Br J Cancer 78:88–95
  PubMed CAS Google Scholar
• Levenson AS, Tonetti DA, Jordan VC (1998) The oestrogen-like effect of 4-hydroxytamoxifen on induction of transforming growth factor alpha mRNA in MDA-MB-231 breast cancer cells stably expressing the oestrogen receptor. Br J Cancer 77:1812–1819
  PubMed CAS Google Scholar
• Levenson AS, Gehm BD, Timm Pearce S et al (2003) Resveratrol acts as an estrogen receptor (ER) agonist in breast cancer cells stably transfected with ERα. Int J Cancer 104:587–596
  Article PubMed CAS Google Scholar
• Wang J, Levenson AS, Satcher RL (2006) Identification of a unique set of genes altered during cell-cell contact in an in vitro model of prostate cancer bone metastasis. Int J Mol Med 17:849–856
  PubMed CAS Google Scholar
• Levenson AS, Svoboda KM, Pease KM et al (2002) Gene expression profiles of the ER-SERM complex in breast cancer cells expressing wtER. Cancer Res 62:4419–4426
  PubMed CAS Google Scholar
• Levenson AS, Jordan VC (1994) Transfection of human estrogen receptor (ER) cDNA into ER-negative mammalian cell lines. J Steroid Biochem Mol Biol 51:229–239
  Article PubMed CAS Google Scholar
• Harris SA, Tau KR, Turner RT et al (1996) Estrogens and progestins. In: Bilezikian JP (ed) Principles of bone biology. Academic Press, San Diego, pp 507–520
  Google Scholar
• Davis VL, Couse JF, Gray TK et al (1994) Correlation between low levels of estrogen receptors and estrogen responsiveness in two rat osteoblast-like cell lines. J Bone Miner Res 9:983–991
  Article PubMed CAS Google Scholar
• Solomayer E-F, Diel IJ, Meyberg GC et al (2000) Metastatic breast cancer: clinical course, prognosis and therapy related to the first site of metastasis. Breast Cancer Res Treat 59:271–278
  Article PubMed CAS Google Scholar
• Coleman RE, Smith P, Rubens RD (1998) Clinical course and prognostic factors following bone recurrence from breast cancer. Br J Cancer 77:336–340
  PubMed CAS Google Scholar
• James JJ, Evans AJ, Pinder SE et al (2003) Bone metastases from breast carcinoma: histopathological-radiological correlations and prognostic features. Br J Cancer 89:660–665
  Article PubMed CAS Google Scholar
• Roger P, Sahla ME, Makela S et al (2001) Decreased expression of estrogen receptor beta protein in proliferative preinvasive mammary tumors. Cancer Res 61:2537–2541
  PubMed CAS Google Scholar
• Shaw JA, Udokang K, Mosquera JM et al (2002) Estrogen receptors alpha and beta differ in normal human breast and breast carcinomas. J Pathol 198:450–457
  Article PubMed CAS Google Scholar
• Hopp TA, Weiss HL, Parra IS et al (2004) Low levels of estrogen receptor beta protein predict resistance to tamoxifen therapy in breast cancer. Clin Cancer Res 10:7490–7499
  Article PubMed CAS Google Scholar
• Bardin A, Boulle N, Lazennec G et al (2004) Loss of ER beta expression as a common step in estrogen-dependent tumor progression. Endocrine-Related Cancer 11:537–551
  Article PubMed CAS Google Scholar
• Wang Y, Klijn JGM, Zhang Y et al (2005) Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet 365:671–679
  PubMed CAS Google Scholar
• Perou CM, Jeffrey SS, van de Rijn M et al (1999) Distinctive gene expression patterns in human mammary epithelial cell and breast cancers. Proc Natl Acad Sci USA 96:9212–9217
  Article PubMed CAS Google Scholar
• Sorlie T, Perou CM, Tibshirani R et al (2001) Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. PNAS 98:10869–10874
  Article PubMed CAS Google Scholar
• Sorlie T, Tibshirani R, Parker J et al (2003) Repeated observation of breast tumor subtypes in independent gene expression data sets. PNAS 100:8418–8423
  Article PubMed CAS Google Scholar
• van’t Veer LJ, Dai H, van de Vijver MJ et al (2002) Gene expression profiling predicts clinical outcome of breast cancer. Nature 415:530–535
  Article CAS Google Scholar
• Weigelt B, Hu Z, He X et al (2005) Molecular portraits and 70-gene prognosis signature are preserved throughout the metastatic process of breast cancer. Cancer Res 65:9155–9158
  Article PubMed CAS Google Scholar
• Ranuncolo SM, Armanasco E, Cresta C et al (2003) Plazma MMP-9 (92 kDA-MMP) activity is useful in the follow-up and in the assessment of prognosis in breast cancer patients. Int J Cancer 106:745–751
  Article PubMed CAS Google Scholar
• Nakopoulou L, Tsirmpa I, Alexandrou P et al (2003) MMP-2 protein in invasive breast cancer and the impact of MMP-2/TIMP-2 phenotype on overall survival. Breast Cancer Res Treat 77:145–155
  Article PubMed CAS Google Scholar
• Dallas SL, Rosser JL, Mundy GR et al (2002) Proteolysis of latent transforming growth factor-beta (TGF-beta)-binding protein-1 by osteoclasts. A cellular mechanism for release of TGF-beta from bone matrix. J Biol Chem 277:21352–21360
  Article PubMed CAS Google Scholar
• Clines GA, Guise TA (2005) Hypercalcaemia of malignancy and basic research on mechanisms responsible for osteolytic and osteoblastic metastasis to bone. Endocrine-Related Cancer 12:549–583
  Article PubMed CAS Google Scholar
• Yue L, Bao Z, Li J (2000) Expression of MacMarcks restores cell adhesion to ICAM-1-coated surface. Cell Adhes Commun 7:359–366
  Article PubMed CAS Google Scholar
• Rakha EA, Boyce RWG, El-Rehim DA et al (2005) Expression of mucins (MUC1, MUC2, MUC3, MUC4, MUC5AC and MUC6) and their prognostic significance in human breast cancer. Modern Pathol 18:1295–1304
  Article CAS Google Scholar
• Komori T (2006) Regulation of osteoblast differentiation by transcription factors. J Cell Biochem 99:1233–1239
  Article PubMed CAS Google Scholar
• Yang J, Mani SA, Weinberg RA (2006) Exploring a new twist on tumor metastasis. Cancer Res 66:4549–4552
  Article PubMed CAS Google Scholar
• Omoto Y, Kobayashi S, Inoue S et al (2002) Evaluation of oestrogen receptor β wild-type and variant protein expression, and relationship with clinicopathological factors in breast cancers. Eur J Cancer 38:380–386
  Article PubMed CAS Google Scholar
• Gruvberger S, Ringner M, Chen Y et al (2001) Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns. Cancer Res 61:5979–5984
  PubMed CAS Google Scholar
• Perou CM, Sorlie T, Eisen MB et al (2000) Molecular portraits of human breast tumours. Nature (Lond) 406:747–752
  Article CAS Google Scholar
• Li J, Aderem A (1992) MacMarcks, a novel member of the Marcks family of protein kinase C cubstrates. Cell 70:791–801
  Article PubMed CAS Google Scholar
• Wu M, Chen DF, Sasaoka T et al (1996) Neural tube defects and abnormal brain development in F52-deficient mice. Proc Natl Acad Sci USA 93:2110–2115
  Article PubMed CAS Google Scholar
• Ramsden JJ (2000) Marcks: a case of molecular exaptation? Int J Biochem Cell Biol 32:475–479
  Article PubMed CAS Google Scholar
• Yue L, Lu S, Garces J et al (2000) Protein kinase C-regulated dynamitin-macrophage-enriched myristoylated alanine-rice C kinase substrate interaction is involved in macrophage cell spreading. J Biol Chem 275:23948–23956
  Article PubMed CAS Google Scholar
• Aderem A (1992) The Marcks brothers: a family of protein kinase C substrates. Cell 71:713–716
  Article PubMed CAS Google Scholar
• Blackshear PJ (1993) The Marcks family of cellular protein kinase C substrates. J Biol Chem 268:1501–1504
  PubMed CAS Google Scholar
• Ohmitsu M, Fukunaga K, Yamamoto H et al (1999) Phosphorylation of Marcks by mitogen-activared protein kinase on cultured rat hippocampal neurons following stimulation of glutamate receptors. J Biol Chem 274:408–417
  Article PubMed CAS Google Scholar
• Manenti S, Malecaze F, Chap H et al (1998) Overexpression of the myristoylated alanine-rich C kinase substrate in human choroidal melanoma cells affects cell proliferation. Cancer Res 58:1429–1434
  PubMed CAS Google Scholar
• Cho SJ, La M-H, Ahn JK et al (2001) Tob-mediated cross-talk between Marcks phosphorylation and erbB-2 activation. Biochem Biophys Res Commun 283:273–277
  Article CAS Google Scholar
• Wesseling J, van der Valk SW, Hilkens J (1996) A mechanism for inhibition of E-cadherin-mediated cell-cell adhesion by the membrane-associated mucin episialin/ Muc1. Mol Biol Cell 7:565–577
  PubMed CAS Google Scholar
• Jarvinen TA, Pelto-Huikko M, Holli K et al (2000) Estrogen receptor beta is coexpressed with ER alpha and PR and associated with nodal status, grade, and proliferation rate in breast cancer. Am J Pathol 156:29–35
  PubMed CAS Google Scholar
• Omoto Y, Inoue S, Ogawa S et al (2001) Clinical value of the wild-type estrogen receptor β expression in breast cancer. Cancer Lett 163:207–212
  Article PubMed CAS Google Scholar
• Bajic VB, Tan SL, Chong A et al (2003) Dragon ERE Finder version 2:a tool for accurate detection and analysis of estrogen response elements in vertebrate genomes. Nucl Acids Res 31:3605–3607
  Article PubMed CAS Google Scholar